• Strategic move facilitates Research Translation

    News

    Strategic move facilitates Research Translation

    Clinical stage oncology drug company Avacta has relocated its Therapeutics division to headquarters at life science cluster Scale Space, in Imperial College’s White City Campus, London, currently home to over 140 companies across a broad range of industries including pharmaceutical and biotech. The move follows the transition of AVA6000, the Company’s lead pre|CISION™ targeted chemotherapy programme and a tumour activated form of doxorubicin, into the clinic in August 2021.

    Dr Fiona McLaughlin, Chief Scientific Officer of Avacta, commented: “This move is the result of a clear vision to bring together the research and development teams into one hub to facilitate the translation of our in-house research from bench to bedside. We are now at the heart of the innovative White City community in London, readily accessible to our collaborators around the world and poised to take Avacta to the next level in its evolution as a clinical stage biopharmaceutical company.”

    Neil Bell, Chief Development Officer of Avacta, commented: “The relocation of Avacta’s Therapeutics division to Scale Space in the heart of Imperial College’s White City Campus is a transformative milestone for our business, as we take the next steps towards developing our innovative oncology pipeline and improving our ability to bring these innovative therapies through to patients. This new location gives Avacta access to world class facilities, increased opportunities for collaboration and access to a significant talent pool to take the business forward.”

    Michael Holmes, CEO of Scale Space, commented: “We are delighted to partner with Avacta in the next phase of their growth – the fact that such an innovative organisation has chosen Scale Space, White City, ahead of any other location they could have picked, is another clear indicator that the White City Innovation District is one of the best locations for businesses looking to immerse themselves in a thriving ecosystem and attract top tier talent to innovate and scale.”

    More information online


    Digital Edition

    ILM 50.2 March 2025

    March 2025

    Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...

    View all digital editions

    Events

    Bio-Europe Spring

    Mar 17 2025 Milan, Italy

    NGVS 2025

    Mar 18 2025 Beijing, China

    Laborama 2025

    Mar 20 2025 Brussels, Belgium

    Asia Labex

    Mar 20 2025 Chandigarh, India

    ACS National Meeting & Expo, Spring 2025

    Mar 23 2025 San Diego, CA, USA

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Labmate for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Laboratory products, news and services. Join us and get the latest Laboratory information first.